• Small Molecules
    • Large Molecules
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Governance Reports & Policies

Corporate Governance Reports

Q1 CORPORATE GOVERNANCE REPORT JUNE 30, 2021
Q4 Corporate Governance Report for Quarter ending - Mar 31, 2021
Q3 CORPORATE GOVERNANCE REPORT - Dec 31, 2020
Q2 CORPORATE GOVERNANCE REPORT - Sep 30, 2020
Q1CORPORATE GOVERNANCE REPORT JUNE 30, 2020
Q4 CORPORATE GOVERNANCE REPORT - March 31, 2020
Q3 CORPORATE GOVERNANCE REPORT December 31, 2019
Q2 CORPORATE GOVERNANCE REPORT - September 30, 2019
Q1 CORPORATE GOVERNANCE REPORT June 30, 2019
Q4 CORPORATE GOVERNANCE REPORT - March 31, 2019
Q3 CORPORATE GOVERNANCE REPORT - December 31, 2018
Q2 CORPORATE GOVERNANCE REPORT September 30, 2018
Q1 CORPORATE GOVERNANCE REPORT - June 30, 2018
Q4 CORPORATE GOVERNANCE REPORT - March 31, 2018
Q3 CORPORATE GOVERNANCE REPORT - December 31, 2017
Q2 CORPORATE GOVERNANCE REPORT - September 30, 2017
Q1 CORPORATE GOVERNANCE REPORT - June 30, 2017
Q4 CORPORATE GOVERNANCE REPORT - March 31, 2017
Q3 CORPORATE GOVERNANCE REPORT - DECEMBER 31, 2016
Q2 CORPORATE GOVERNANCE REPORT - September 30, 2016
Q1 CORPORATE GOVERNANCE REPORT - June 30, 2016
Q4 CORPORATE GOVERNANCE REPORT - 31 Mar 2016
Q3 CORPORATE GOVERNANCE REPORT Dec 31, 2015
Q2 QUATERLY COMPLIANCE REPORT ON CORPORATE GOVERNANCE - September 30, 2015

Governance Documents & Policies

Policy on Director’s Appointment and Remuneration
Environment, Occupational Health, Safety and Sustainability Policy
Policy for Preservation of Documents
Policy for Determining Materiality for Disclosures
Syngene - Memorandum of Association & Articles of Association
Code of Conduct for Prevention of Insider Trading
Corporate Social Responsibility Policy
Integrity and Whistle-blower Policy
Dividend Distribution Policy
Policy document on Board Diversity
Policy on Related Party Transactions
Familiarisation Policy and Details of Familiarisation Programme
Letter of Appointment for Independent Directors
Code of Conduct and Duties for Independent Directors
Code of Ethics and Business Conduct
Supplier code of conduct
Purchase order terms and conditions
Safety Instructions For Service Provider
Safety Instructions For Suppliers
Service order terms and conditions

Syngene has engaged various vendors for delivery of goods and services. Some of such vendors qualify as micro, small and medium enterprises (“MSME”) under the Micro, Small and Medium Enterprises Development Act, 2006 (“Act”). To ensure timely payment and resolution to queries for outstanding unreconciled balances, vendors are requested to reach out to Accounts Helpdesk- Accounts.Helpdesk@Syngeneintl.com

To download, Please share your details

To download, Please share your details